ENB-105 is under development for the treatment of inflammatory bowel disease and immune checkpoint inhibitor colitis (ICI-Colitis). It is being developed based on eSTEM systems biology platform.

EV68-228-N is under development for the treatment of EV-D68 infection and acute flaccid myelitis (AMF). It is a monoclonal antibody acts against enterovirus EV-D68 capsid protein and is administered ...

Nearly 200 nations at the Cop28 climate summit in Dubai agreed to the deal, which calls on them to "transition away" from ... who had called for the term "phase out" of fossil fuels to be used ...

Deconfined quantum criticality represents a novel class of phase transitions that fall outside ... material candidates show a weakly-first order transition. Here the authors introduce a Nordic ...

which will allow officials to meet with counterparts at departments and agencies ahead of the January transition of power. Pushpa 2 box office Day 13: Allu Arjun's film remains unstoppable People ...

The trial’s primary endpoint found that deupirfenidone was superior to placebo in slowing the rate of ... randomised Phase IIb WHISTLE-PF trial in Australia. "PureTech sees success in Phase ...